bluebird bio, Inc. (BLUE)

bluebird bio Market Cap

bluebird bio has a market cap or net worth of $172.70 million as of April 25, 2024. Its market cap has decreased by -52.11% in one year.

• Market Cap: 172.70M
• Enterprise Value: 307.30M
• 1-Year Change: -52.11%
• Ranking: #3723
• Category: Micro-Cap
• Stock Price: $0.90

Market Cap Chart

Since June 19, 2013, bluebird bio's market cap has decreased from $588.50M to $172.70M, a decrease of -70.65%. That is a compound annual growth rate of -10.68%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	106.20M	1.82%
Apr 22, 2024	104.30M	-6.46%
Apr 19, 2024	111.50M	7.01%
Apr 18, 2024	104.20M	-1.04%
Apr 17, 2024	105.30M	-2.68%
Apr 16, 2024	108.20M	-3.91%
Apr 15, 2024	112.60M	-6.40%
Apr 12, 2024	120.30M	-5.13%
Apr 11, 2024	126.80M	-2.54%
Apr 10, 2024	130.10M	-5.59%
Apr 9, 2024	137.80M	8.68%
Apr 8, 2024	126.80M	-5.72%
Apr 5, 2024	134.50M	-
Apr 4, 2024	134.50M	4.26%
Apr 3, 2024	129.00M	-2.49%
Apr 2, 2024	132.30M	-2.43%
Apr 1, 2024	135.60M	-3.14%
Mar 28, 2024	140.00M	-6.17%
Mar 27, 2024	149.20M	13.72%
Mar 26, 2024	131.20M	-11.77%
Mar 25, 2024	148.70M	-0.73%
Mar 22, 2024	149.80M	-6.14%
Mar 21, 2024	159.60M	4.25%
Mar 20, 2024	153.10M	-
Mar 19, 2024	153.10M	-2.73%

View and export this data all the way back to 2013. Sign Up Today.

Related Stocks

Company	Market Cap
Cardiff Oncology	193.45M
Generation Bio Co.	192.56M
Trevi Therapeutics	192.40M
Acumen Pharmaceuticals	191.04M
Rigel Pharmaceuticals	190.29M
Cellectis	189.42M
Elevation Oncology	188.28M
Akoya Biosciences	188.21M